Destiny Pharma raises £4.8m

Brighton-based pharmaceutical company Destiny Pharma has raised £4.8 million from a consortium, including existing shareholders, to fund further trials of its medicines. The consortium was led by Longbow Capital LLP, which specialises in backing early-stage healthcare companies

Marc Barber

Marc was editor of GrowthBusiness from 2006 to 2010. He specialised in writing about entrepreneurs, private equity and venture capital, mid-market M&A, small caps and high-growth businesses. More by Marc Barber